Remote fetal monitoring for high-risk pregnancies in Missouri
Official title: Study of Fetal Health Outcomes: Working With a Missouri E-telehealth Platform
Run by University of Missouri-Columbia · NCT06741735 · Data updated 2026-11-12
This study is testing if a new home monitoring system can help pregnant women with high-risk pregnancies feel more satisfied and save money compared to going to the clinic for regular check-ups.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 110 (estimated) |
| Sponsor | University of Missouri-Columbia Academic / other |
| Locations | 2 sites (Columbia, Missouri and 1 other locations) |
| Status | Recruiting |
| Started | December 19, 2024 |
| Main results expected | December 2026 |
| Study ends | December 2027 |
| Registry record updated | September 16, 2026 |
| Trial ID | NCT06741735 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are English-speaking pregnant individuals over 18 years old with singleton gestation requiring antenatal testing between 32-40 weeks and having Missouri Medicaid insurance.
✕Probably not a fit
Patients with multiple gestations or significant co-morbidities not listed in the inclusion criteria may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the use of the NUVO remote fetal monitoring system, allowing pregnant patients requiring weekly non-stress tests to conduct these tests from home. The study aims to assess patient and provider satisfaction, as well as cost savings associated with remote monitoring compared to traditional in-clinic testing. Participants will complete pre-implementation surveys and be randomly assigned to either the remote monitoring or in-clinic testing groups. The study also includes qualitative analyses through focus groups to understand barriers and predictors of use.
Why it matters
Potential benefit: If successful, this approach could enhance patient satisfaction and reduce costs associated with fetal monitoring during high-risk pregnancies.
How similar studies have gone: Other studies have shown promise in using telehealth for remote monitoring, indicating potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria * English Speaking * \> 18 years of age * Singleton gestation * Missouri Medicaid as primary insurance (paid by study), offered to patients with private insurance for self-pay * Requires antenatal testing between 32-40 weeks according to institutional policies * One of the following indications for fetal NST: * Gestational diabetes * Well-controlled type II diabetes * Chronic hypertension without evidence of placental insufficiency * Advanced maternal age * Obesity (as defined as BMI \>30 and \<45) * Android or iOS system-operated telephone or tablet * Home or work access to reliable internet (WIFI screening completed by research personnel) Exclusion Criteria * Multiple gestations * Additional co-morbidities not listed in the inclusion criteria * PPROM or evidence of preterm labor * Oligohydramnios of \< 5 cm of polyhydramnios \> 30 * Co-existing fetal complications: FGR, placenta or vasa previa, fetal chromosomal or structural anomaly, recent (within a week) fetal testing of a BPP \< 8/10 prior to enrollment * Intention to transfer care to different provider during the pregnancy * Currently institutionalized or incarcerated * Inability to consent for oneself * \<18 years of age * History of prior stillbirth * Lack of access to reliable internet * Abdominal skin disorder that prevents use of the INVO device
Where it's running
-
University of Missouri
Columbia, Missouri, United States Recruiting -
University of Missouri - Kansas City
Kansas City, Missouri, United States Recruiting
Study contacts
- Study coordinator: Karen Florio, DO MPH
- Email: floriok@health.missouri.edu
- Phone: (573) 817-6526
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pregnant Women Living with HIV on Bictegravir/Emtricitabine/Tenofovir Alafenamide
This study looks at how B/F/TAF is used in pregnant women with HIV and whether it helps maintain viral suppression from before conception through delivery.
-
Pelvic Floor Training and a Modified Lumbopelvic Belt for Symphysis Pubis Pain in Pregnancy
This study tests whether pelvic floor muscle training plus a modified lumbopelvic belt can reduce pain and improve function for pregnant women with symphysis pubis pain.
-
Effective Communication in VBAC Counseling
This study tests how clearly doctors and midwives explain VBAC options during prenatal visits and whether patients feel understood.
-
Innovative Multidisciplinary and Virtual Care for IBD in Pregnancy
This study tests a dedicated IBD pregnancy care model, including a new virtual approach, to see if it improves access and quality of care for pregnant people with Crohn's disease or ulcerative colitis.
-
Compare spinal-epidural versus general anesthesia for babies after cesarean delivery
This trial tests whether the type of anesthesia used for cesarean delivery affects newborn hearing in babies.
-
Pregnant women weight-management support via an app and care model
Aims to try a smartphone-based weight-management program plus professional support for pregnant women to see if it helps manage gestational weight and promote healthy behaviors.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.